CoChat

Improving the Sexual Quality of Life of Couples Affected by Erectile Dysfunction: A Double–Blind, Randomized, Placebo–Controlled Trial of Vardenafil

Fisher, William A., Rosen, Raymond C., Mollen, Martin, Brock, Gerald, Karlin, Gary, Pommerville, Peter, Goldstein, Irwin, Bangerter, Keith, Bandel, Tiemo-Joerg, Derogatis, Leonard R., Sand, Michael · 2005 · The Journal of Sexual Medicine
Cited by 147

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Introduction: Erectile dysfunction (ED) has a dual negative impact on men and their female partners; both are likely to face a drop in sexual quality of life and challenges to their intimate relationship as couples’ sexual activities are curtailed by the loss of erectile function. Aim: The primary objective of this study was to compare the efficacy of vardenafil vs. placebo in terms of success of maintenance of erection in men with ED and improvement of their female partner’s sexual quality of life. Methods: This was a randomized, double–blind, multicenter, flexible–dose, parallel–group comparison of vardenafil vs. placebo for 12 weeks in men (≥18 years) with ED of ≥ 6 months duration, and their female partners. Main Outcome Measures: Changes in patient’s overall response rate to Sexual Encounter Profile question 3 (SEP3) “Did your erection last long enough for you to have sexual intercourse?” and female partner’s response to the quality of life domain of the modified Sexual Life Quality Questionnaire (mSLQQ–QOL) at last observation carried forward (LOCF) were considered the primary efficacy measures. In addition, patient’s response to SEP2 “Were you able to insert your penis into your partner’s vagina?,” the erectile function domain of the International Index of Erectile Function (IIEF–EF) and patient’s mSLQQ–QOL score were also assessed. Results: Compared with placebo, vardenafil significantly improved overall least square (LS) mean per–patient SEP3 success rate (28% vs. 68%; P < 0.0001) and partner’s LS mean (standard error [SE]) mSLQQ–QOL score at LOCF (32.14 [3.24] vs. 65.80 [3.10]; P < 0.0001). In addition, compared with placebo, vardenafil also improved overall LS mean per–patient SEP2 success rate (47% vs. 80%; P < 0.0001), LS mean (SE) IIEF–EF scores at LOCF (12.7 [0.8] vs. 22.8 [0.8]; P < 0.0001) and patient’s LS mean (SE) mSLQQ–QOL (28.37 [3.46] vs. 63.85 [3.28]; P < 0.0001) at LOCF. Conclusions: Vardenafil improved erectile function in men with ED and improved the sexual quality of life of the couple.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1743-6109.2005.00119.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 147

Metadata

Authors
Fisher, W. A., Rosen, R. C., Mollen, M., Brock, G., Karlin, G., Pommerville, P., Goldstein, I., Bangerter, K., Bandel, T.-J., Derogatis, L. R., & Sand, M.
Venue
The Journal of Sexual Medicine
Published
2005-09-01
Volume
2
Issue
5
Pages
699-708
ISSN
  • 1743-6095 (ISSN-L)
  • 1743-6109
OpenAlex
W2120672455
Cited by
147
References
9
FWCI
6.05
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improving the Sexual Quality of Life of Couples Affected by Erectile Dysfunction: A Double–Blind, Randomized, Placebo–Controlled Trial of Vardenafil. https://app.cochat.ai/papers/10.1111/j.1743-6109.2005.00119.x
The paper
Fisher, W. A., Rosen, R. C., Mollen, M., Brock, G., Karlin, G., Pommerville, P., Goldstein, I., Bangerter, K., Bandel, T.-J., Derogatis, L. R., & Sand, M. (2005). Improving the Sexual Quality of Life of Couples Affected by Erectile Dysfunction: A Double–Blind, Randomized, Placebo–Controlled Trial of Vardenafil. The Journal of Sexual Medicine. https://doi.org/10.1111/j.1743-6109.2005.00119.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.